Hirosato Ebiike

Title: Hirosato Ebiike: Innovator in Aminopyrazole Derivatives

Introduction

Hirosato Ebiike is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of low-molecular-weight compounds that inhibit Src family kinases. With a total of 5 patents to his name, Ebiike's work is paving the way for advancements in cancer treatment.

Latest Patents

Ebiike's latest patents focus on aminopyrazole derivatives. One of his inventions aims to provide compounds that can effectively inhibit Src family kinases. These compounds are represented by a general formula that includes various substituents, allowing for a range of pharmacologically acceptable salts. Another patent outlines a method for treating cancer, which involves administering a composition containing these aminopyrazole derivatives. The detailed chemical structures and functional groups in his patents highlight the innovative approaches he is taking in drug development.

Career Highlights

Throughout his career, Hirosato Ebiike has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Chugai Pharmaceutical Co., Ltd. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in developing novel therapeutic compounds.

Collaborations

Ebiike has collaborated with several talented individuals in his field. Among his coworkers are Masami Kochi and Hiroki Nishii, who have also contributed to advancements in medicinal chemistry.

Conclusion

Hirosato Ebiike is a distinguished inventor whose work in aminopyrazole derivatives is making a significant impact in cancer treatment. His innovative approaches and collaborations with leading pharmaceutical companies underscore his contributions to the field.